Results 211 to 220 of about 117,026 (248)
Some of the next articles are maybe not open access.
Somatostatin analogs: does pharmacology impact antitumor efficacy?
Trends in Endocrinology and Metabolism, 2014Philippe J Caron +2 more
exaly
The history of somatostatin analogs.
Journal of endocrinological investigation, 2006In the middle of the last century, there was a spectacular progress in the discovery, characterization and synthesis of neuropeptides. This was only possible because increasingly sophisticated analytical and isolation technology was becoming available.
openaire +1 more source
Adverse events associated with somatostatin analogs in acromegaly
Expert Opinion on Drug Safety, 2015Annamaria Colao +2 more
exaly
Somatostatin Analogs as Radiodiagnostic Tools
Reviews in Endocrine and Metabolic Disorders, 2005Wouter W, de Herder +1 more
openaire +2 more sources
Somatostatin analogs in the diagnosis and treatment of cancer
Trends in Endocrinology and Metabolism, 2002Wouter W de Herder, Steven W J Lamberts
exaly
A selective analog for the somatostatin sst1-receptor subtype expressed by human tumors
European Journal of Pharmacology, 1998Jean Claude Reubi +2 more
exaly
Somatostatin analog octreotide LAR® in gastro–entero–pancreatic tumors
Expert Review of Anticancer Therapy, 2009Kjell Öberg
exaly
Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
Expert Opinion on Pharmacotherapy, 2017Gherardo Mazziotti +2 more
exaly